z-logo
Premium
Serum sTREM ‐1 (Soluble Triggering Receptor Expressed on Myeloid Cells‐1) Associates Negatively with Embryo Quality in Infertility Patients
Author(s) -
HallerKikkatalo Kadri,
Sarapik Aili,
Faure Gilbert C.,
Béné MarieChristine,
Massin Frédéric,
Salumets Andres,
Uibo Raivo
Publication year - 2012
Publication title -
american journal of reproductive immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.071
H-Index - 97
eISSN - 1600-0897
pISSN - 1046-7408
DOI - 10.1111/j.1600-0897.2011.01102.x
Subject(s) - follicular fluid , follicular phase , embryo quality , medicine , infertility , myeloid , andrology , biomarker , endocrinology , receptor , biology , immunology , embryo , in vitro fertilisation , pregnancy , oocyte , biochemistry , genetics , microbiology and biotechnology
Problem Soluble triggering receptor expressed on myeloid cells‐1 ( sTREM ‐1) is a useful biomarker of infection and inflammation. Method of study We studied serum and follicular fluid sTREM ‐1 in infertile patients ( N  = 110) utilizing enzyme‐linked immunosorbent assay. Results Serum and follicular sTREM ‐1 were in good correlation (Pearson's correlation 0.56, P  < 0.0001) with higher values in follicular fluid (140.4 ± 34.4 and 115.6 ± 35.1 pg/ mL , t ‐test, P  < 0.0001). Endometriosis associated with lower follicular and serum sTREM ‐1 compared with male factor infertility patients (age‐adjusted r  = −25.7 pg/ mL , P  = 0.018; r  = −22.1 pg/ mL , P  = 0.030). No associations between follicular or serum sTREM ‐1 and clinical parameters were found, except higher serum sTREM ‐1 associated with lower embryo quality in all patients (adjusted r  = −0.3%, P  = 0.033), with a cutoff value between 111.5 and 113.3 pg/ mL (OR = 0.38, P  = 0.048; OR = 0.34, P  = 0.028) predicting that more than 39% of embryos would be with good quality. Conclusion Serum sTREM ‐1 could represent a prognostic marker for female fecundity, probably indicating impaired inflammatory reaction of immune system.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here